Ordination Univ. Prof. Dr. Smola
 

   ORDINATION PRIVATKLINIK RAGNITZ

Anmeldung/Sekretariat
Operationen/Aufklärung
Kongress/Urlaub
Persönliche Daten CV
Brustkrebshilfe
www.onkonet.at
NewsWissen
Brustkrebshilfe Hotline
MedConsulting
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
Seite hinzufügen
 

   Med Univ Graz MUG

Vorlesungen
wiss. Publikationen
MammaAmbulanz
AG Mammachirurgie
MitarbeiterInnen
wiss.Projekte
PsychoOnkologie
Weltverband
International
Fotogalerie
Journal
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
no name yet
Seite hinzufügen

Meine Publikationen - my publications  /   Meine Vorträge international


PUBMED: 40, Citations: 123
search Pubmed for Smola M and Smola MG; list of international cited publications;

BIOMEDEXPERTS: 29
biomedexperts -  see more

Published articles: 223 – original papers, abstracts, bookchapters – english, german, Oral Presentations: 192 – english, german; invited chairs & lectures 52 (international)


Excerpt publications (pubmed): 16 of 40

 1. Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Filipits M, Rudas M, et al.  Austrian Breast and Colorectal Cancer Study Group. Clin Cancer Res. 2009 Sep 15;15(18):5888-94. Epub 2009 Sep 1.PMID: 19723645 [PubMed - indexed for MEDLINE]Related citations

 2. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. Gnant M, Mlineritsch B, et al. ABCSG-12 Trial Investigators. N Engl J Med. 2009 Feb 12;360(7):679-91. Erratum in: N Engl J Med. 2009 May 28;360(22):2379. PMID: 19213681 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

 3. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Gnant M, Mlineritsch B, et al. Austrian Breast and Colorectal Cancer Study Group (ABCSG). Lancet Oncol. 2008 Sep;9(9):840-9. Epub 2008 Aug 19.PMID: 18718815 [PubMed - indexed for MEDLINE]Related citations

 4. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy. Dubsky P, Sevelda P, et al; Austrian Breast and Colorectal Cancer Study Group.Clin Cancer Res. 2008 Apr 1;14(7):2082-7.PMID: 18381948 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

 5. Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy. Rudas M, Lehnert M, et al. Austrian Breast and Colorectal Cancer Study Group. Clin Cancer Res. 2008 Mar 15;14(6):1767-74.PMID: 18347178 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

6. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07). Taucher S, Steger GG, et al. Gnant M; Austrian Breast and Colorectal Cancer Study Group-07.Breast Cancer Res Treat. 2008 Nov;112(2):309-16. Epub 2007 Dec 14.PMID: 18080748 [PubMed - indexed for MEDLINE]Related citations

7. Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Cataliotti L, De Wolf C, Holland R, Marotti L, Perry N, Redmond K, Rosselli Del Turco M, Rijken H, Kearney N, Ellis IO, Di Leo A, Orecchia R, Noel A, Andersson M, Audretsch W, Bjurstam N, Blamey RW, Blichert-Toft M, Bosmans H, Burch A, Bussolati G, Christiaens MR, Colleoni M, Cserni G, Cufer T, Cush S, Damilakis J, Drijkoningen M, Ellis P, Foubert J, Gambaccini M, Gentile E, Guedea F, Hendriks J, Jakesz R, Jassem J, Jereczek-Fossa BA, Laird O, Lartigau E, Mattheiem W, O'higgins N, Pennery E, Rainsbury D, Rutgers E, Smola M, Van Limbergen E, von Smitten K, Wells C, Wilson R; EUSOMA. Eur J Cancer. 2007 Mar;43(4):660-75. Epub 2007 Feb 5.PMID: 17276672 [PubMed - indexed for MEDLINE]Related citations

 8. Verrucous carcinoma of the skin: long-term follow-up results following surgical therapy.Koch H, Kowatsch E, Hödl S, Smola MG, Radl R, Hofmann T, Scharnagl E. Dermatol Surg. 2004 Aug;30(8):1124-30.PMID: 15274703 [PubMed - indexed for MEDLINE]Related citations

9. Impact of pretreatment thrombocytosis on survival in primary breast cancer. Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, et al.  Austrian Breast and Colorectal Cancer Study Group. Thromb Haemost. 2003 Jun;89(6):1098-106.PMID: 12783124 [PubMed - indexed for MEDLINE]Related citations

 10. Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer. Kronberger L, Steinschifter W, Weblacher M, Estelberger W, Liebmann PM, Rabl H, Smola M, Lax SF, Mischinger HJ, Schauenstein E, Schauenstein K. Breast Cancer Res Treat. 2000 Nov;64(2):193-9.PMID: 11194455 [PubMed - indexed for MEDLINE]Related citations

 11. European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group. O'Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wolf C, Rochard F, Rutgers EJ, Roberts PJ, Mattheiem W, da Silva MA, Holmberg L, Schulz KD, Smola MG, Mansel RE. Ann Chir Gynaecol. 1998;87(1):110-2.PMID: 9598249 [PubMed - indexed for MEDLINE]Related citations

 12. Principles and guidelines for surgeons--management of symptomatic breast cancer. On behalf of the European Society of Surgical Oncology. Blichert-Toft M, Smola MG, Cataliotti L, O'Higgins N. Ann Chir Gynaecol. 1998;87(1):101-9.PMID: 9598248 [PubMed - indexed for MEDLINE]Related citations

 13. European guidelines for quality assurance in the surgical management of mammographically detected lesions.O'Higgins N, Linos DA, Blichert-Toft M, Cataliotti L, de Wolf C, Rochard F, Rutgers EJ, Roberts P, Mattheiem W, da Silva MA, Holmberg L, Schulz KD, Smola MG, Mansel RE. Eur J Surg Oncol. 1998 Apr;24(2):96-8. Review. No abstract available. PMID: 9591022 [PubMed - indexed for MEDLINE]Related citations

14. Experience with a high speed biopsy gun in breast cancer diagnosis. Cerwenka H, Hoff M, Rosanelli G, Hauser H, Thalhammer M, Smola MG, Klimpfinger M. Eur J Surg Oncol. 1997 Jun;23(3):206-7.PMID: 9236891 [PubMed - indexed for MEDLINE]Related citations

 15. Principles and guidelines for surgeons--management of symptomatic breast cancer. European Society of Surgical Oncology.Blichert-Toft M, Smola MG, Cataliotti L, O'Higgins N. Eur J Surg Oncol. 1997 Apr;23(2):101-9. Review.PMID: 9158182 [PubMed - indexed for MEDLINE]Related citations

 16. Primary malignant non-Hodgkin's lymphoma of the breast: breast preserving therapy in 3 patients] Taus P, Smola M, Starz I, Petru E, Höfler G, Kronberger L.Gynakol Geburtshilfliche Rundsch. 1997;37(2):68-70. German. PMID: 9445632 [PubMed - indexed for MEDLINE]Related citations




edit